|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Hydralazine#Adverse Reactions]] |
| {{Hydralazine}}
| |
| {{CMG}}; {{AE}} {{AK}}
| |
| | |
| ==Adverse Reactions==
| |
| Adverse reactions with hydralazine are usually reversible when dosage is reduced. However, in some cases it may be necessary to discontinue the drug. The following adverse reactions have been observed, but there has not been enough systematic collection of data to support an estimate of their frequency.
| |
| ===Common===
| |
| [[headache]], [[anorexia]], [[nausea]], vomiting, diarrhea, palpitations, tachycardia, angina pectoris.
| |
| ===Less Frequent===
| |
| ====Digestive====
| |
| [[constipation]], [[paralytic ileus]].
| |
| ====Cardiovascular====
| |
| [[hypotension]], paradoxical pressor response, [[edema]].
| |
| ====Respiratory====
| |
| [[dyspnea]].
| |
| ====Neurologic====
| |
| [[peripheral neuritis]], evidenced by [[paresthesia]], [[numbness]], and [[tingling]]; [[dizziness]]; [[tremors]]; [[muscle cramps]]; psychotic reactions characterized by [[depression]], [[disorientation]], or [[anxiety]].
| |
| ====Genitourinary====
| |
| difficulty in [[urination]].
| |
| ====Hematologic====
| |
| blood dyscrasias, consisting of reduction in hemoglobin and red cell count, [[leukopenia]], [[agranulocytosis]], [[purpura]]; [[lymphadenopathy]]; [[splenomegaly]].
| |
| | |
| ====Hypersensitive Reactions====
| |
| [[rash]], [[urticaria]], [[pruritus]], [[fever]], [[chills]], [[arthralgia]], [[eosinophilia]], and rarely, [[hepatitis]].
| |
| ====Other====
| |
| nasal congestion, [[flushing]], [[lacrimation]], [[conjunctivitis]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = HYDRALAZINE HYDROCHLORIDE INJECTION [FRESENIUS KABI USA, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c3797028-c625-4f70-ae69-8a5f6f23f1b8 | publisher = | date = | accessdate = 10 March 2014 }}</ref>
| |
| | |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |